相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A fluorescent sensor for spatiotemporally resolved imaging of endocannabinoid dynamics in vivo
Ao Dong et al.
NATURE BIOTECHNOLOGY (2022)
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice
Lindsey Shapiro et al.
NEUROPHARMACOLOGY (2021)
Multiple cannabinoid signaling cascades powerfully suppress recurrent excitation in the hippocampus
Kyle R. Jensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex A Placebo-Controlled Randomized Clinical Trial
Elizabeth A. Thiele et al.
JAMA NEUROLOGY (2021)
Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments
Valentina Satta et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy
Willian Lazarini-Lopes et al.
EPILEPSY & BEHAVIOR (2021)
In vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activity
Jordan S. Farrell et al.
NEURON (2021)
Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg
Andrew J. Roebuck et al.
NEUROPHARMACOLOGY (2021)
Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents
Guo-Hua Bi et al.
ADDICTION BIOLOGY (2020)
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome A Randomized Clinical Trial
Ian Miller et al.
JAMA NEUROLOGY (2020)
Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders
Luisa Rocha et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2020)
Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics
Ying Yu et al.
MOLECULAR NEUROBIOLOGY (2020)
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Edward Chesney et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs
Philip N. Patsalos et al.
EPILEPSIA (2020)
Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway
Isabel Vieira de Assis Lima et al.
NEUROPHARMACOLOGY (2020)
Cannabidiol interactions with voltage-gated sodium channels
Lily Goodyer Sait et al.
ELIFE (2020)
Cannabinoid Receptor Type 1 (CB1R) Expression in Limbic Brain Structures After Acute and Chronic Seizures in a Genetic Model of Epilepsy
Willian Lazarini-Lopes et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2020)
Long-term efficacy and safety of cannabidiol (CBD) in children with treatment-resistant epilepsy: Results from a state-based expanded access program
Yong D. Park et al.
EPILEPSY & BEHAVIOR (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Synergistic action of CB1 and 5-HT2B receptors in preventing pilocarpine-induced status epilepticus in rats
Roberto Colangeli et al.
NEUROBIOLOGY OF DISEASE (2019)
Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice
Lindsey Shapiro et al.
EPILEPSIA (2019)
Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
Pabitra Hriday Patra et al.
EPILEPSIA (2019)
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet
Gaetano Terrone et al.
EPILEPSIA (2018)
Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model
Archie A. Khan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling
Yuki Sugaya et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Positron emission tomography imaging of cerebral glucose metabolism and type 1 cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys
Evy Cleeren et al.
EPILEPSIA (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
Alex Straiker et al.
MOLECULAR PHARMACOLOGY (2018)
Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons
Alexander Stumpf et al.
NEUROPHARMACOLOGY (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice
Jana Tchekalarova et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
Jerzy P. Szaflarski et al.
EPILEPSY & BEHAVIOR (2018)
Cannabinoid receptor 1/2 double-knockout mice develop epilepsy
Shane Rowley et al.
EPILEPSIA (2017)
Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced damage to hippocampal neurons: Dependence on the degree of injury
Irina B. Mikheeva et al.
EPILEPSY RESEARCH (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
Joshua S. Kaplan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry
Raissa Lerner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility
Stephan Guggenhuber et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain
Emma Leishman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol
Reesha R. Patel et al.
BRAIN (2016)
High-Throughput, High-Resolution Mapping of Protein Localization in Mammalian Brain by In Vivo Genome Editing
Takayasu Mikuni et al.
CELL (2016)
Cannabinoids and Cytochrome P450 Interactions
Ondrej Zendulka et al.
CURRENT DRUG METABOLISM (2016)
Presynaptic inhibition upon CB1 or mGlu2/3 receptor activation requires ERK/MAPK phosphorylation of Munc18-1
Sabine K. Schmitz et al.
EMBO JOURNAL (2016)
The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats
Cristiane R. de Carvalho et al.
EPILEPSY RESEARCH (2016)
Deletion of CB2 Cannabinoid Receptors Reduces Synaptic Transmission and Long-Term Potentiation in the Mouse Hippocampus
Yong Li et al.
HIPPOCAMPUS (2016)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
Presynaptic Protein Synthesis Is Required for Long-Term Plasticity of GABA Release
Thomas J. Younts et al.
NEURON (2016)
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
A. Vanessa Stempel et al.
NEURON (2016)
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling
Bo Feng et al.
SCIENTIFIC REPORTS (2016)
Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures
Yuki Sugaya et al.
CELL REPORTS (2016)
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors
Iraj Aghaei et al.
EPILEPSY RESEARCH (2015)
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release
Sang-Hun Lee et al.
JOURNAL OF NEUROSCIENCE (2015)
Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice
E. L. von Rueden et al.
NEUROBIOLOGY OF DISEASE (2015)
Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm
E. L. von Rueden et al.
NEUROBIOLOGY OF DISEASE (2015)
CANNABINOID AND NITRIC OXIDE SIGNALING INTERPLAY IN THE MODULATION OF HIPPOCAMPAL HYPEREXCITABILITY: STUDY ON ELECTROPHYSIOLOGICAL AND BEHAVIORAL MODELS OF TEMPORAL LOBE EPILEPSY IN THE RAT
F. Carletti et al.
NEUROSCIENCE (2015)
Interference of TRPV1 function altered the susceptibility of PTZ-induced seizures
Yun-Fang Jia et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents
Guy Griebel et al.
SCIENTIFIC REPORTS (2015)
Disease-Modifying Effects of RHC80267 and JZL184 in a Pilocarpine Mouse Model of Temporal Lobe Epilepsy
Lei Ma et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting
Filomena Fezza et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2014)
ABHD6 Blockade Exerts Antiepileptic Activity in PTZ-Induced Seizures and in Spontaneous Seizures in R6/2 Mice
Alipi V. Naydenov et al.
NEURON (2014)
Modulation of Pilocarpine-Induced Seizures by Cannabinoid Receptor 1
Rebecca L. Kow et al.
PLOS ONE (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats
Luciano R. Vilela et al.
EPILEPSY RESEARCH (2013)
Anandamide, Cannabinoid Type 1 Receptor, and NMDA Receptor Activation Mediate Non-Hebbian Presynaptically Expressed Long-Term Depression at the First Central Synapse for Visceral Afferent Fibers
Abdessattar Khlaifia et al.
JOURNAL OF NEUROSCIENCE (2013)
Cannabinoid CB1 Receptor in Dorsal Telencephalic Glutamatergic Neurons: Distinctive Sufficiency for Hippocampus-Dependent and Amygdala-Dependent Synaptic and Behavioral Functions
Sabine Ruehle et al.
JOURNAL OF NEUROSCIENCE (2013)
Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity
Brian N. Mathur et al.
NATURE NEUROSCIENCE (2013)
Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1-Mediated Antinociceptive and Gastroprotective Effects
Steven G. Kinsey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Acute Cannabinoids Impair Working Memory through Astroglial CB1 Receptor Modulation of Hippocampal LTD
Jing Han et al.
CELL (2012)
Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures
Shyamshree S. S. Manna et al.
EPILEPSY RESEARCH (2012)
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids
Antonio Luchicchi et al.
MOLECULAR NEUROBIOLOGY (2012)
Patterns of treatment response in newly diagnosed epilepsy
M. J. Brodie et al.
NEUROLOGY (2012)
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo et al.
NEURON (2012)
Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage
Sonja Kallendrusch et al.
PLOS ONE (2012)
Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression
Asami Tanimura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
Nicholas A. Jones et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis
Karolien Goffin et al.
BRAIN (2011)
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
Sabatino Maione et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice
Hannes Wendt et al.
EPILEPSIA (2011)
Pharmacological Activation of Kainate Receptors Drives Endocannabinoid Mobilization
Joana Lourenco et al.
JOURNAL OF NEUROSCIENCE (2011)
Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum
Peng Zhong et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Modulation of Anticonvulsant Effects of Cannabinoid Compounds by GABA-A Receptor Agonist in Acute Pentylenetetrazole Model of Seizure in Rat
Nima Naderi et al.
NEUROCHEMICAL RESEARCH (2011)
Incidence of epilepsy A systematic review and meta-analysis
A. K. Ngugi et al.
NEUROLOGY (2011)
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy
Andrea Romigi et al.
EPILEPSIA (2010)
Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans
Zsofia Magloczky et al.
EPILEPSIA (2010)
WAG/Rij rats show a reduced expression of CB1 receptors in thalamic nuclei and respond to the CB1 receptor agonist, R(+)WIN55,212-2, with a reduced incidence of spike-wave discharges
Clementina M. van Rijn et al.
EPILEPSIA (2010)
Selective Reduction of Cholecystokinin-Positive Basket Cell Innervation in a Model of Temporal Lobe Epilepsy
Megan S. Wyeth et al.
JOURNAL OF NEUROSCIENCE (2010)
Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice
Ying Gao et al.
JOURNAL OF NEUROSCIENCE (2010)
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
Nicholas A. Jones et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus
Andres E. Chavez et al.
NATURE NEUROSCIENCE (2010)
Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens
Brad A. Grueter et al.
NATURE NEUROSCIENCE (2010)
The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission
Asami Tanimura et al.
NEURON (2010)
AAV Vector-Mediated Overexpression of CB1 Cannabinoid Receptor in Pyramidal Neurons of the Hippocampus Protects against Seizure-Induced Excitoxicity
Stephan Guggenhuber et al.
PLOS ONE (2010)
Endocannabinoid Signaling and Long-Term Synaptic Plasticity
Boris D. Heifets et al.
ANNUAL REVIEW OF PHYSIOLOGY (2009)
Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus
Katherine W. Falenski et al.
BRAIN RESEARCH (2009)
Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model
Julio Echegoyen et al.
EPILEPSY RESEARCH (2009)
Development of Spontaneous Recurrent Seizures after Kainate-Induced Status Epilepticus
Philip A. Williams et al.
JOURNAL OF NEUROSCIENCE (2009)
Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study
Jakob Christensen et al.
LANCET (2009)
Ketogenic diet is anti epileptogenic in pentylenetetrazole kindled mice and decrease levels of N-acylethanolamines in hippocampus
Suzanne L. Hansen et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Endocannabinoid-Mediated Control of Synaptic Transmission
Masanobu Kano et al.
PHYSIOLOGICAL REVIEWS (2009)
Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus
Aniko Ludanyi et al.
JOURNAL OF NEUROSCIENCE (2008)
Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus
Hiroki Yasuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin
Boris D. Heifets et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Beta-caryophyllene is a dietary cannabinoid
Juerg Gertsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
Jacqueline L. Blankman et al.
CHEMISTRY & BIOLOGY (2007)
Enclocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons
Takako Ohno-Shosaku et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage
David A. Karanian et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1α
Vivien Chevaleyre et al.
NEURON (2007)
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor
H. Donald Burns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ca2+-assisted receptor-driven endocannabinoid release:: mechanisms that associate presynaptic and postsynaptic activities
Yuki Hashimotodani et al.
CURRENT OPINION IN NEUROBIOLOGY (2007)
Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat
Karolien Goffin et al.
EXPERIMENTAL NEUROLOGY (2007)
Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy
K. W. Falenski et al.
NEUROSCIENCE (2007)
Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus
Yuki Hashimotodani et al.
JOURNAL OF NEUROSCIENCE (2007)
Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures
Kang Chen et al.
JOURNAL OF NEUROSCIENCE (2007)
Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus
Axel Neu et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
The endocannabinoid system controls key epileptogenic circuits in the hippocampus
Krisztina Monory et al.
NEURON (2006)
In silico patent searching reveals a new cannabinoid receptor
D Baker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Synaptic and vascular associations of neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex
H Wang et al.
CEREBRAL CORTEX (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase C β4 signaling cascade in the cerebellum
T Maejima et al.
JOURNAL OF NEUROSCIENCE (2005)
Phospholipase Cβ serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal
Y Hashimotodani et al.
NEURON (2005)
Two distinct classes of muscarinic action on hippocampal inhibitory synapses:: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling
Y Fukudome et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors
R Clinckers et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Molecular characterization of a phospholipase D generating anandamide and its congeners
Y Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons
A Losonczy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling
SC Azad et al.
JOURNAL OF NEUROSCIENCE (2004)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
T Bisogno et al.
JOURNAL OF CELL BIOLOGY (2003)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy
MJ Wallace et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability
V Chevaleyre et al.
NEURON (2003)
Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis
P Desjardins et al.
NEUROCHEMISTRY INTERNATIONAL (2003)
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity
MJ Wallace et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
D Robbe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses
T Ohno-Shosaku et al.
JOURNAL OF NEUROSCIENCE (2002)
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
GL Gerdeman et al.
NATURE NEUROSCIENCE (2002)
Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus
N Varma et al.
JOURNAL OF NEUROSCIENCE (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors
T Maejima et al.
NEURON (2001)
Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons
CC Huang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
RI Wilson et al.
NATURE (2001)
Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals
T Ohno-Shosaku et al.
NEURON (2001)
Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells
AC Kreitzer et al.
NEURON (2001)
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol
CJ Hillard
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
D Smart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
